Literature DB >> 16829190

Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1.

Lei Ye1, Husnain Kh Haider, Shujia Jiang, Ru San Tan, Ruowen Ge, Peter K Law, Eugene K W Sim.   

Abstract

OBJECTIVE: To achieve angiogenic interaction between VEGF(165) and angiopoietin-1 (Ang-1) using a novel adenoviral bicistronic vector (Ad-Bic) encoding the two factors and delivered ex vivo using sex-mismatched human skeletal myoblasts. METHODS AND
RESULTS: A myocardial infarction model was developed in 29 female pigs; randomised into four groups: DMEM (group-1, n=6); Adenovirus null (Ad-null) vector-myoblast (group-2, n=5); Ad-Ang-1 myoblast (group 3, n=7) and Ad-Bic-myoblast (group-4, n=11). Three weeks later, 5 ml DMEM without myoblasts or containing 3 x 10(8) myoblasts carrying lac-z gene and transduced with Ad-null, Ad-Ang-1 or Ad-Bic were injected intra-myocardially in and around the infarct. 2D-echocardiography and fluorescent microsphere studies 6- and 12-weeks post-treatment revealed significantly improved cardiac performance and regional blood flow in groups 3 and 4. Histological studies and Y-chromosome analysis revealed extensive survival of lac-z positive myoblasts staining positive for human proteins in the pig heart. ELISA, immunostaining and RT-PCR revealed that Ad-Bic transduced myoblasts concomitantly but transiently expressed hVEGF(165) and Ang-1 both in vitro and in vivo. Double fluorescent immunostaining of the tissue sections for vWFactor-III and smooth muscle actin showed significantly higher vascular density of mature blood vessels per low power microscopic field in groups 3 and 4 at 6- and 12-weeks.
CONCLUSION: Our combined approach led to enhanced angiogenesis with a greater percentage of functionally mature blood vessels in a porcine heart.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16829190     DOI: 10.1016/j.ejheart.2006.04.008

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  16 in total

Review 1.  Nonviral vector gene modification of stem cells for myocardial repair.

Authors:  Husnain K Haider; Ibrahim Elmadbouh; Michel Jean-Baptiste; Muhammad Ashraf
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

Review 2.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

3.  Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.

Authors:  Juliana C Small; Raj K Kurupati; Xiangyang Zhou; Ang Bian; Emily Chi; Yan Li; Zhiquan Xiang; Hildegund C J Ertl
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

4.  Genesis of myocardial repair with cardiac progenitor cells and tissue engineering.

Authors:  Eugene K W Sim; Husnain Kh Haider; Nermine Lila; Olivier Schussler; Juan C Chachques; Lei Ye
Journal:  Heart Asia       Date:  2010-09-18

Review 5.  Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.

Authors:  Peter A Campochiaro; Kevin G Peters
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

6.  Transmurally differentiated measurement of ATP hydrolysis rates in the in vivo porcine hearts.

Authors:  Albert Jang; Qiang Xiong; Pengyuan Zhang; Jianyi Zhang
Journal:  Magn Reson Med       Date:  2016-02-19       Impact factor: 4.668

Review 7.  Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2008-05-10       Impact factor: 5.000

8.  Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart.

Authors:  Hua Su; Junya Takagawa; Yu Huang; Janice Arakawa-Hoyt; Jennifer Pons; William Grossman; Yuet Wai Kan
Journal:  Int J Cardiol       Date:  2008-03-04       Impact factor: 4.164

9.  Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.

Authors:  Qiang Xiong; Lei Ye; Pengyuan Zhang; Michael Lepley; Jinfeng Tian; Jun Li; Liying Zhang; Cory Swingen; J Thomas Vaughan; Dan S Kaufman; Jianyi Zhang
Journal:  Circulation       Date:  2013-01-31       Impact factor: 29.690

10.  Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic angiogenesis.

Authors:  Seung-Hwa Shin; Jangwook Lee; Dong-Gyun Ahn; Kuen Yong Lee
Journal:  Pharm Res       Date:  2013-05-18       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.